Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems


Bristol’s Yervoy falls short in prostate cancer study

Bristol-Myers Squibb Co’s immunotherapy drug Yervoy failed to significantly prolong survival among patients with advanced prostate cancer who had previously received chemotherapy, according to limited data from the first late-stage study of the drug for the condition.

Yervoy (ipilimumab) frees the immune system to attack and kill cancer cells by blocking the action of… Bristol’s Yervoy falls short in prostate cancer study   

tgen1 - end-stage renal failure1 - metastatic tumours1 - kidney failure37 - psa-test1 - hyperoxaluria4 - bju international1 - epidemiology1 - aspirin2 - early stage prostate cancer1 - urinary stones6 - urinary system2 - fatty fish1 - noninvasive imaging1 - renal arteries2 - retinal hemorrhages1 - focal segmental glomerulosclerosis2 - male pattern baldness1 - urethral sphincter2 - prostate cancer cells2 - diabetic kidney failure1 - swimming1 - low-dose prednisone1 - sexual abuse1 - urinary phosphate2 - ultrasonic wave1 - risk of kidney stones1 - ultrasonic imaging1 - ureteral calculi1 - anxiety1 -